Yong Ling - Search Results

Year	Number of Results
2007	1
2009	2
2010	2
2011	8
2012	6
2013	8
2014	9
2015	9
2016	5
2017	15
2018	10
2019	11
2020	14
2021	21
2022	25
2023	28
2024	6

1

Disease progression model of 4T1 metastatic breast cancer.

Yang L, Yong L, Zhu X, Feng Y, Fu Y, Kong D, Lu W, Zhou TY. Yang L, et al. Among authors: yong l. J Pharmacokinet Pharmacodyn. 2020 Feb;47(1):105-116. doi: 10.1007/s10928-020-09673-5. Epub 2020 Jan 22. J Pharmacokinet Pharmacodyn. 2020. PMID: 31970615

2

Air-Working Electrochromic Artificial Muscles.

Ling Y, Li L, Liu J, Li K, Hou C, Zhang Q, Li Y, Wang H. Ling Y, et al. Adv Mater. 2024 Feb;36(5):e2305914. doi: 10.1002/adma.202305914. Epub 2023 Dec 5. Adv Mater. 2024. PMID: 37899672

3

Advances in microRNA from adipose-derived mesenchymal stem cell-derived exosome: focusing on wound healing.

Ma J, Yong L, Lei P, Li H, Fang Y, Wang L, Chen H, Zhou Q, Wu W, Jin L, Sun D, Zhang X. Ma J, et al. Among authors: yong l. J Mater Chem B. 2022 Nov 30;10(46):9565-9577. doi: 10.1039/d2tb01987f. J Mater Chem B. 2022. PMID: 36398750 Review.

4

Overview of piperlongumine analogues and their therapeutic potential.

Zhu P, Qian J, Xu Z, Meng C, Zhu W, Ran F, Zhang W, Zhang Y, Ling Y. Zhu P, et al. Among authors: ling y. Eur J Med Chem. 2021 Aug 5;220:113471. doi: 10.1016/j.ejmech.2021.113471. Epub 2021 Apr 21. Eur J Med Chem. 2021. PMID: 33930801 Review.

5

Nanoparticles: Oral Delivery for Protein and Peptide Drugs.

Cao SJ, Xu S, Wang HM, Ling Y, Dong J, Xia RD, Sun XH. Cao SJ, et al. Among authors: ling y. AAPS PharmSciTech. 2019 May 20;20(5):190. doi: 10.1208/s12249-019-1325-z. AAPS PharmSciTech. 2019. PMID: 31111296 Free PMC article. Review.

6

Genotoxicity Evaluation of Titanium Dioxide Nanoparticles In Vivo and In Vitro: A Meta-Analysis.

Cao Y, Chen J, Bian Q, Ning J, Yong L, Ou T, Song Y, Wei S. Cao Y, et al. Among authors: yong l. Toxics. 2023 Oct 27;11(11):882. doi: 10.3390/toxics11110882. Toxics. 2023. PMID: 37999534 Free PMC article. Review.

7

The Insights and Perspectives of Nitric Oxide-mediated Biofilm Eradication.

Yuan M, Sun T, Wu J, Fei Y, Yang Y, Ling Y, Zhang Y, Huang Z. Yuan M, et al. Among authors: ling y. Curr Top Med Chem. 2021;21(24):2213-2229. doi: 10.2174/1568026621666210701113043. Curr Top Med Chem. 2021. PMID: 34218787 Review.

8

Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.

Ran F, Liu Y, Wang C, Xu Z, Zhang Y, Liu Y, Zhao G, Ling Y. Ran F, et al. Among authors: ling y. Eur J Med Chem. 2022 Feb 5;229:114009. doi: 10.1016/j.ejmech.2021.114009. Epub 2021 Nov 22. Eur J Med Chem. 2022. PMID: 34839996 Review.

9

Recent development of BTK-based dual inhibitors in the treatment of cancers.

Ran F, Liu Y, Xu Z, Meng C, Yang D, Qian J, Deng X, Zhang Y, Ling Y. Ran F, et al. Among authors: ling y. Eur J Med Chem. 2022 Apr 5;233:114232. doi: 10.1016/j.ejmech.2022.114232. Epub 2022 Feb 25. Eur J Med Chem. 2022. PMID: 35247756 Review.

10

The Catsper channel and its roles in male fertility: a systematic review.

Sun XH, Zhu YY, Wang L, Liu HL, Ling Y, Li ZL, Sun LB. Sun XH, et al. Among authors: ling y. Reprod Biol Endocrinol. 2017 Aug 15;15(1):65. doi: 10.1186/s12958-017-0281-2. Reprod Biol Endocrinol. 2017. PMID: 28810916 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

153 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year